<DOC>
	<DOCNO>NCT02989285</DOCNO>
	<brief_summary>Human Immunodeficiency Virus ( HIV ) remain infected patient receive highly active antiretroviral therapy ( HAART ) many year . Stopping HAART usually lead re-emergence small reservoir latent ( inactive ) HIV reside inside certain type infect cell , replicate cause full HIV infection . Chronic HIV infection also lead long-term immune activation associate high incidence serious non-AIDS event include cardiovascular disease cancer . Thus HIV+ patient must remain HAART indefinitely replication-competent latent HIV reservoirs must eradicate . The central nervous system ( CNS ) sanctuary site latent HIV . For example , HIV-associated neurocognitive disorder ( HAND ) develop persist 40 % HIV+ person despite long-term HAART viral suppression blood cerebrospinal fluid ( CSF ) . Continued CSF immune activation also frequently observe despite viral suppression . Both likely indicate ongoing low-level HIV replication CNS . Several strategy eradicate latent HIV explore . One , know `` shock kill '' involve `` awaken '' latent HIV induce replication make susceptible host immune response HAART . However , several major caveat application CNS risk trigger serious immunoinflammatory response ( e.g. , meningoencephalitis ) easily control HAART . Other eradication strategy may also problematic give many latency-reversing agent limited penetration blood brain barrier limit efficacy astrocyte cell . To improve effectiveness new eradication therapy crucial develop good method identify quantify latent HIV reservoir site great precision . To identify potential HIV latency biomarkers CNS , investigator study HIV+ patient stable HAART virally-suppressed blood CSF 24 month . Because marker associate HAND development without change significantly HAND progression , half sample HAND study entry half . Patients undergo neuropsychological test give blood CSF sample every 6 month identify candidate biomarkers track prospectively HAND development progression . MRI brain scan also occur study entry 24 month .</brief_summary>
	<brief_title>Identification Quantification HIV CNS Latency Biomarkers</brief_title>
	<detailed_description />
	<mesh_term>Neurocognitive Disorders</mesh_term>
	<criteria>HIVinfected Aged &gt; 18 year On HAART viral load suppression ( &lt; 50 copy / ml ) plasma CSF least 6 month Able provide inform consent NonHIV relate neurological disorder active CNS opportunistic infection assess full blood count , electrolytes , creatinine , glucose , liver function test , venereal disease reaction level ( VDRL ) , MRI brain scan CSF analysis cell count , protein , glucose , culture , VDRL cryptococcal antigen Psychiatric disorder psychotic axis , current major depression , current substance use disorder and/or 12 month history severe substance use disorder Active Hepatitis C coinfection History severe traumatic brain injury ( posttraumatic amnesia ( PTA ) duration &gt; 1 day ) loss consciousness &gt; 30 minute cause ( e.g. , hypoxic brain injury ) Nonproficient English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>HIV-associated neurocognitive disorder ( HAND )</keyword>
	<keyword>Neurology</keyword>
	<keyword>Latent HIV</keyword>
	<keyword>HIV Reservoirs</keyword>
</DOC>